Hypotrichosis And Recurrent Skin Vesicles
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
A homozygous nonsense mutation in the human desmocollin-3 (DSC3) gene underlies hereditary hypotrichosis and recurrent skin vesicles.
|
19765682 |
2009 |
Hypotrichosis And Recurrent Skin Vesicles
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A homozygous nonsense mutation in the human desmocollin-3 (DSC3) gene underlies hereditary hypotrichosis and recurrent skin vesicles.
|
19765682 |
2009 |
Hypotrichosis And Recurrent Skin Vesicles
|
0.710 |
GermlineCausalMutation
|
disease |
ORPHANET |
A homozygous nonsense mutation in the human desmocollin-3 (DSC3) gene underlies hereditary hypotrichosis and recurrent skin vesicles.
|
19765682 |
2009 |
Hypotrichosis And Recurrent Skin Vesicles
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hypotrichosis And Recurrent Skin Vesicles
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Malignant neoplasm of breast
|
0.330 |
Biomarker
|
disease |
CTD_human |
Two examples include the antimetastatic, tumor suppressor genes, desmocollin 3 (DSC3) and MASPIN, which are frequently silenced in this manner in human breast cancer.
|
16799634 |
2007 |
Breast Carcinoma
|
0.330 |
Biomarker
|
disease |
CTD_human |
Two examples include the antimetastatic, tumor suppressor genes, desmocollin 3 (DSC3) and MASPIN, which are frequently silenced in this manner in human breast cancer.
|
16799634 |
2007 |
Mammary Neoplasms
|
0.330 |
Biomarker
|
group |
CTD_human |
5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.
|
16799634 |
2007 |
Malignant neoplasm of breast
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
DSC3 expression was downregulated in 23 of 32 (72%) breast cancer specimens comprising: 22 invasive ductal carcinomas, 7 invasive lobular breast carcinomas, 2 invasive ductal carcinomas that metastasized to the lymph node, and a mucoid ductal carcinoma.
|
16168112 |
2005 |
Breast Carcinoma
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
DSC3 expression was downregulated in 23 of 32 (72%) breast cancer specimens comprising: 22 invasive ductal carcinomas, 7 invasive lobular breast carcinomas, 2 invasive ductal carcinomas that metastasized to the lymph node, and a mucoid ductal carcinoma.
|
16168112 |
2005 |
Mammary Neoplasms
|
0.330 |
AlteredExpression
|
group |
LHGDN |
We also used a quantitative real-time RT-PCR approach, and analyzed all breast tumor specimens for DSC3 expression.
|
16168112 |
2005 |
Mammary Neoplasms
|
0.330 |
AlteredExpression
|
group |
BEFREE |
We also used a quantitative real-time RT-PCR approach, and analyzed all breast tumor specimens for DSC3 expression.
|
16168112 |
2005 |
Malignant neoplasm of breast
|
0.330 |
Biomarker
|
disease |
BEFREE |
Gene-profiling experiments of breast cancer cells infected with wt p53 revealed both MASPIN and desmocollin 3 (DSC3) to be p53-target genes, even though both genes are silenced in association with aberrant cytosine methylation of their promoters.
|
12789271 |
2003 |
Breast Carcinoma
|
0.330 |
Biomarker
|
disease |
BEFREE |
Gene-profiling experiments of breast cancer cells infected with wt p53 revealed both MASPIN and desmocollin 3 (DSC3) to be p53-target genes, even though both genes are silenced in association with aberrant cytosine methylation of their promoters.
|
12789271 |
2003 |
Mammary Neoplasms
|
0.330 |
Biomarker
|
group |
LHGDN |
Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression.
|
12789271 |
2003 |
Malignant neoplasm of breast
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
Northern analysis, quantitative real-time polymerase chain reaction assay and Western blot analysis showed that desmocollin 3 is present in normal and immortalized human mammary epithelial cells, but consistently exhibits a significant, and often complete, down-regulation in breast cancer cell lines and primary breast tumors, both at the mRNA and protein levels.
|
11408939 |
2001 |
Breast Carcinoma
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
Northern analysis, quantitative real-time polymerase chain reaction assay and Western blot analysis showed that desmocollin 3 is present in normal and immortalized human mammary epithelial cells, but consistently exhibits a significant, and often complete, down-regulation in breast cancer cell lines and primary breast tumors, both at the mRNA and protein levels.
|
11408939 |
2001 |
Mammary Neoplasms
|
0.330 |
AlteredExpression
|
group |
BEFREE |
Northern analysis, quantitative real-time polymerase chain reaction assay and Western blot analysis showed that desmocollin 3 is present in normal and immortalized human mammary epithelial cells, but consistently exhibits a significant, and often complete, down-regulation in breast cancer cell lines and primary breast tumors, both at the mRNA and protein levels.
|
11408939 |
2001 |
Mammary Neoplasms, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.
|
16799634 |
2007 |
Mammary Carcinoma, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.
|
16799634 |
2007 |
Hypotrichosis
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Recent desmosomal genodermatoses described include lethal congenital epidermolysis bullosa (plakoglobin), cardiomyopathy with alopecia and palmoplantar keratoderma (plakoglobin), hypotrichosis with scalp vesicles (desmocollin 3), and generalized peeling skin disease (corneodesmosin).
|
21929534 |
2012 |
Hypotrichosis
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor rCBV estimates were obtained using DSC T2* perfusion analysis.
|
31134296 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Furthermore, the new method can potentially extract more tumor physiological information from DSC MRI comparing to the traditional model-based analysis and morphological analysis of tumor heterogeneity, thus may improve the characterizations of gliomas for better diagnosis and treatment decisions.
|
31176951 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Desmocollin 3 has a tumor suppressive activity through inhibition of AKT pathway in colorectal cancer.
|
30857973 |
2019 |